Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$57.92 - $72.58 $7.25 Million - $9.09 Million
-125,256 Closed
0 $0
Q4 2021

Jan 11, 2022

SELL
$64.88 - $73.64 $276,064 - $313,338
-4,255 Reduced 3.29%
125,256 $9.1 Million
Q3 2021

Oct 13, 2021

BUY
$67.69 - $73.03 $8.77 Million - $9.46 Million
129,511 New
129,511 $9.05 Million
Q3 2020

Oct 08, 2020

SELL
$62.1 - $78.08 $12.2 Million - $15.4 Million
-197,024 Closed
0 $0
Q2 2020

Jul 17, 2020

SELL
$72.34 - $84.0 $792,267 - $919,968
-10,952 Reduced 5.27%
197,024 $15.2 Million
Q1 2020

Apr 09, 2020

BUY
$62.63 - $80.22 $13 Million - $16.7 Million
207,976 New
207,976 $15.5 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Churchill Management Corp Portfolio

Follow Churchill Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Churchill Management Corp with notifications on news.